Cetera Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$3.64M Buy
38,090
+24,242
+175% +$2.32M 0.03% 574
2023
Q4
$1.06M Sell
13,848
-1,307
-9% -$99.7K 0.01% 751
2023
Q3
$1.05M Sell
15,155
-371
-2% -$25.7K 0.02% 706
2023
Q2
$1.46M Buy
15,526
+156
+1% +$14.7K 0.02% 575
2023
Q1
$1.27M Sell
15,370
-857
-5% -$70.9K 0.02% 604
2022
Q4
$1.21M Sell
16,227
-4,571
-22% -$341K 0.02% 593
2022
Q3
$2K Buy
20,798
+9,350
+82% +$899 ﹤0.01% 1295
2022
Q2
$1.09M Buy
11,448
+1,084
+10% +$103K 0.02% 546
2022
Q1
$1.22M Buy
10,364
+1,301
+14% +$153K 0.02% 553
2021
Q4
$1.17M Sell
9,063
-1,545
-15% -$200K 0.02% 540
2021
Q3
$1.2M Buy
10,608
+1,953
+23% +$221K 0.02% 547
2021
Q2
$896K Buy
8,655
+1,606
+23% +$166K 0.02% 583
2021
Q1
$590K Sell
7,049
-7,033
-50% -$589K 0.02% 675
2020
Q4
$1.29M Buy
14,082
+735
+6% +$67.1K 0.04% 364
2020
Q3
$1.07M Buy
13,347
+1,439
+12% +$115K 0.04% 366
2020
Q2
$823K Buy
+11,908
New +$823K 0.04% 406
2020
Q1
Sell
-7,077
Closed -$548K 847
2019
Q4
$548K Buy
7,077
+192
+3% +$14.9K 0.02% 529
2019
Q3
$505K Sell
6,885
-306
-4% -$22.4K 0.02% 543
2019
Q2
$443K Sell
7,191
-93
-1% -$5.73K 0.02% 596
2019
Q1
$466K Buy
7,284
+2,340
+47% +$150K 0.02% 513
2018
Q4
$251K Sell
4,944
-639
-11% -$32.4K 0.01% 686
2018
Q3
$322K Buy
5,583
+570
+11% +$32.9K 0.02% 701
2018
Q2
$243K Sell
5,013
-120
-2% -$5.82K 0.01% 742
2018
Q1
$239K Buy
+5,133
New +$239K 0.01% 680
2015
Q2
Sell
-19,614
Closed -$466K 719
2015
Q1
$466K Buy
19,614
+3,264
+20% +$77.5K 0.04% 399
2014
Q4
$341K Buy
16,350
+318
+2% +$6.63K 0.03% 448
2014
Q3
$274K Buy
16,032
+1,236
+8% +$21.1K 0.02% 467
2014
Q2
$210K Buy
+14,796
New +$210K 0.02% 534